About P&T JournalContacts:
Statement of Purpose
Guidelines for Authors
Drug Shortages (4-Part Series)
When it comes to influenza vaccines, the timing of the distribution can create both shortages and surpluses.
Keiji Fukuda, MD, MPH, Dennis O’Mara, and James A. Singleton, MS
Lawrence M. Prescott, PhD
The withdrawl of Baycol illustrates the need for better monitoring of patients and adverse reactions.
Ivan Goldsmith, MD, Ross W. Newman, and William Dachman, MD
This article discusses both the conventional treatment and investigational agents for this disease.
Dena M. Behm Dillon, PharmD and Linda M. Schrand, PharmD
Editor-in-Chief David B. Nash would like all health systems to be more like “Learning Organizations.”
David Nash, MD, MBA
The latest information about approvals, indication
changes, industry updates, and news from the FDA.
A new antifungal agent to treat a broad spectrum of mycoses.
Nicholas S. Vanni, PharmD and Michael T. Inzerillo, RPh
Matthew Grissinger, RPh, cautions all health care
providers about the dangers of enteral nutrition containers.